$530 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 74 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 93.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | Buy | IMMUNOMEDICS INC | $109,080,000 | +15.8% | 6,750,000 | +0.2% | 20.59% | +22.0% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $49,191,000 | +40.9% | 1,087,104 | +8.7% | 9.29% | +48.4% |
| IWM | Sell | ISHARES TRput | $38,115,000 | -44.7% | 250,000 | -46.2% | 7.20% | -41.7% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $31,136,000 | +17.1% | 3,892,000 | +13.4% | 5.88% | +23.3% |
| XBI | Sell | SPDR SERIES TRUSTput | $29,705,000 | -38.7% | 350,000 | -37.5% | 5.61% | -35.5% |
| VCYT | VERACYTE INC | $21,517,000 | -25.5% | 3,295,111 | 0.0% | 4.06% | -21.6% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $21,272,000 | +17.4% | 531,000 | +6.2% | 4.02% | +23.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $20,394,000 | +317.1% | 323,000 | +49.4% | 3.85% | +339.5% |
| KDMN | Buy | KADMON HLDGS INC | $17,792,000 | +59.3% | 4,915,000 | +47.5% | 3.36% | +67.9% |
| VRAY | Buy | VIEWRAY INC | $17,739,000 | +131.2% | 1,915,654 | +43.8% | 3.35% | +143.6% |
| IRIX | IRIDEX CORP | $15,240,000 | -18.7% | 2,000,000 | 0.0% | 2.88% | -14.3% | |
| CEMI | CHEMBIO DIAGNOSTICS INC | $14,115,000 | +32.3% | 1,721,299 | 0.0% | 2.66% | +39.3% | |
| INTEC PHARMA LTD JERUSALEM | $14,030,000 | -42.5% | 2,724,283 | 0.0% | 2.65% | -39.4% | ||
| ZGNX | Buy | ZOGENIX INC | $12,015,000 | +37.1% | 300,000 | +20.0% | 2.27% | +44.5% |
| EDGE | Sell | EDGE THERAPEUTICS INC | $8,844,000 | -34.2% | 943,906 | -24.7% | 1.67% | -30.7% |
| CBIO | New | CATALYST BIOSCIENCES INC | $6,138,000 | – | 450,000 | +100.0% | 1.16% | – |
| AVXS | New | AVEXIS INC | $5,854,000 | – | 52,900 | +100.0% | 1.10% | – |
| EVH | Sell | EVOLENT HEALTH INCcl a | $5,166,000 | -35.5% | 420,000 | -6.7% | 0.98% | -32.1% |
| FXI | ISHARES TRput | $4,617,000 | +4.8% | 100,000 | 0.0% | 0.87% | +10.5% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $4,419,000 | -15.4% | 900,000 | -9.7% | 0.83% | -10.9% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $4,341,000 | – | 311,169 | +100.0% | 0.82% | – |
| SGEN | Buy | SEATTLE GENETICS INCcall | $4,280,000 | +96.7% | 80,000 | +100.0% | 0.81% | +107.2% |
| CASM | Buy | CAS MED SYS INC | $3,973,000 | -15.2% | 5,160,000 | +1.3% | 0.75% | -10.7% |
| Buy | NABRIVA THERAPEUTICS PLC | $3,468,000 | +5.9% | 580,000 | +45.0% | 0.66% | +11.6% | |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INcall | $3,148,000 | – | 80,000 | +100.0% | 0.59% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $2,829,000 | – | 155,000 | +100.0% | 0.53% | – |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $2,710,000 | -57.7% | 90,000 | -47.1% | 0.51% | -55.4% |
| RMTI | Buy | ROCKWELL MED INCput | $2,561,000 | +19.7% | 440,000 | +76.0% | 0.48% | +26.0% |
| LOXO | New | LOXO ONCOLOGY INCput | $2,525,000 | – | 30,000 | +100.0% | 0.48% | – |
| FENC | FENNEC PHARMACEUTICALS INC | $2,505,000 | -9.7% | 250,000 | 0.0% | 0.47% | -4.8% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INCcall | $2,409,000 | -8.6% | 80,000 | +14.3% | 0.46% | -3.8% |
| AGIO | New | AGIOS PHARMACEUTICALS INCput | $2,287,000 | – | 40,000 | +100.0% | 0.43% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $2,281,000 | – | 92,500 | +100.0% | 0.43% | – |
| VIVE | Sell | VIVEVE MED INC | $2,154,000 | -50.3% | 433,419 | -47.6% | 0.41% | -47.6% |
| NKTR | New | NEKTAR THERAPEUTICScall | $2,150,000 | – | 36,000 | +100.0% | 0.41% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL INcall | $2,133,000 | – | 46,000 | +100.0% | 0.40% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTLcall | $2,078,000 | – | 100,000 | +100.0% | 0.39% | – |
| EDIT | New | EDITAS MEDICINE INCcall | $1,967,000 | – | 64,000 | +100.0% | 0.37% | – |
| OSUR | New | ORASURE TECHNOLOGIES INCput | $1,886,000 | – | 100,000 | +100.0% | 0.36% | – |
| CRSP | New | CRISPR THERAPEUTICS AGcall | $1,878,000 | – | 80,000 | +100.0% | 0.36% | – |
| NKTR | New | NEKTAR THERAPEUTICSput | $1,792,000 | – | 30,000 | +100.0% | 0.34% | – |
| AMAG | Buy | AMAG PHARMACEUTICALS INCput | $1,756,000 | +90.2% | 132,500 | +165.0% | 0.33% | +101.2% |
| JUNO | New | JUNO THERAPEUTICS INCcall | $1,691,000 | – | 37,000 | +100.0% | 0.32% | – |
| NTLA | New | INTELLIA THERAPEUTICS INCcall | $1,653,000 | – | 86,000 | +100.0% | 0.31% | – |
| STML | New | STEMLINE THERAPEUTICS INCcall | $1,638,000 | – | 105,000 | +100.0% | 0.31% | – |
| SGEN | Sell | SEATTLE GENETICS INCput | $1,605,000 | -57.9% | 30,000 | -57.1% | 0.30% | -55.6% |
| EXEL | New | EXELIXIS INCcall | $1,520,000 | – | 50,000 | +100.0% | 0.29% | – |
| TDOC | Buy | TELADOC INCput | $1,394,000 | +40.1% | 40,000 | +33.3% | 0.26% | +47.8% |
| NVTA | Sell | INVITAE CORP | $1,383,000 | -72.0% | 152,300 | -71.2% | 0.26% | -70.6% |
| ALIM | ALIMERA SCIENCES INC | $1,296,000 | -1.4% | 974,318 | 0.0% | 0.24% | +3.8% | |
| EDIT | New | EDITAS MEDICINE INCput | $1,229,000 | – | 40,000 | +100.0% | 0.23% | – |
| NEOS | New | NEOS THERAPEUTICS INCcall | $1,178,000 | – | 115,500 | +100.0% | 0.22% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INCput | $1,151,000 | – | 52,500 | +100.0% | 0.22% | – |
| VRAY | New | VIEWRAY INCcall | $1,111,000 | – | 120,000 | +100.0% | 0.21% | – |
| MDCO | New | MEDICINES COcall | $1,094,000 | – | 40,000 | +100.0% | 0.21% | – |
| IMDZ | New | IMMUNE DESIGN CORP | $1,069,000 | – | 274,100 | +100.0% | 0.20% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INCput | $996,000 | – | 55,000 | +100.0% | 0.19% | – |
| GKOS | Buy | GLAUKOS CORPput | $795,000 | -19.7% | 31,000 | +3.3% | 0.15% | -15.3% |
| EVTC | Sell | EVERTEC INCput | $751,000 | -31.1% | 55,000 | -20.1% | 0.14% | -27.2% |
| MNTA | New | MOMENTA PHARMACEUTICALS INCcall | $646,000 | – | 46,300 | +100.0% | 0.12% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $632,000 | -86.0% | 43,900 | -85.4% | 0.12% | -85.3% |
| MDXG | Sell | MIMEDX GROUP INCput | $631,000 | -24.2% | 50,000 | -28.6% | 0.12% | -20.1% |
| ONCE | New | SPARK THERAPEUTICS INCput | $514,000 | – | 10,000 | +100.0% | 0.10% | – |
| MNKD | Sell | MANNKIND CORPput | $400,000 | -47.4% | 172,500 | -50.7% | 0.08% | -44.1% |
| EVH | Sell | EVOLENT HEALTH INCcall | $400,000 | -72.9% | 32,500 | -60.8% | 0.08% | -71.3% |
| AVEO | New | AVEO PHARMACEUTICALS INC | $347,000 | – | 124,338 | +100.0% | 0.07% | – |
| LXRX | Sell | LEXICON PHARMACEUTICALS INCput | $321,000 | -34.8% | 32,500 | -18.8% | 0.06% | -30.7% |
| NEOS | New | NEOS THERAPEUTICS INCput | $255,000 | – | 25,000 | +100.0% | 0.05% | – |
| TRXC | New | TRANSENTERIX INCput | $203,000 | – | 105,000 | +100.0% | 0.04% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $88,000 | – | 11,000 | +100.0% | 0.02% | – |
| TGTX | New | TG THERAPEUTICS INCcall | $82,000 | – | 10,000 | +100.0% | 0.02% | – |
| ONS | ONCOBIOLOGICS INC | $38,000 | -5.0% | 29,082 | 0.0% | 0.01% | 0.0% | |
| MNTA | New | MOMENTA PHARMACEUTICALS INCput | $35,000 | – | 2,500 | +100.0% | 0.01% | – |
| AVEO | New | AVEO PHARMACEUTICALS INCcall | $33,000 | – | 12,000 | +100.0% | 0.01% | – |
| ONSIZ | Exit | ONCOBIOLOGICS INC*w exp 05/18/201 | $0 | – | -96,833 | -100.0% | -0.00% | – |
| ONSIW | Exit | ONCOBIOLOGICS INC*w exp 02/18/201 | $0 | – | -96,833 | -100.0% | -0.00% | – |
| OTIC | Exit | OTONOMY INCcall | $0 | – | -17,500 | -100.0% | -0.01% | – |
| AXGT | Exit | AXOVANT SCIENCES LTDcall | $0 | – | -20,300 | -100.0% | -0.02% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Acall | $0 | – | -9,000 | -100.0% | -0.07% | – |
| CBMX | Exit | COMBIMATRIX CORPORATION | $0 | – | -111,912 | -100.0% | -0.15% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -71,500 | -100.0% | -0.19% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCput | $0 | – | -20,000 | -100.0% | -0.19% | – |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INCput | $0 | – | -60,000 | -100.0% | -0.24% | – |
| CBMXW | Exit | COMBIMATRIX CORPORATION*w exp 03/18/202 | $0 | – | -564,200 | -100.0% | -0.25% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -58,525 | -100.0% | -0.26% | – |
| GOGO | Exit | GOGO INCput | $0 | – | -135,000 | -100.0% | -0.29% | – |
| NITE | Exit | NIGHTSTAR THERAPEUTICS PLCadr | $0 | – | -100,000 | -100.0% | -0.34% | – |
| CNC | Exit | CENTENE CORP DELput | $0 | – | -20,000 | -100.0% | -0.35% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -15,000 | -100.0% | -0.38% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INCcall | $0 | – | -151,000 | -100.0% | -0.41% | – |
| LCI | Exit | LANNET INCput | $0 | – | -127,500 | -100.0% | -0.42% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -569,145 | -100.0% | -0.50% | – |
| TOCA | Exit | TOCAGEN INC | $0 | – | -251,112 | -100.0% | -0.56% | – |
| ZGNX | Exit | ZOGENIX INCput | $0 | – | -160,000 | -100.0% | -1.00% | – |
| JNJ | Exit | JOHNSON & JOHNSONput | $0 | – | -45,000 | -100.0% | -1.05% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -80,000 | -100.0% | -1.18% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -192,000 | -100.0% | -1.46% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Aput | $0 | – | -200,000 | -100.0% | -1.52% | – |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -667,500 | -100.0% | -1.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.